Skip to main content

Table 3 Results of guideline assessment with AGREE

From: Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines

  CEBAM HAS ACP KDIGO KHA-CARI BCMA NICE UMHS VA-DoD mean range
Scope and Purpose 72% 75% 81% 100% 61% 58% 75% 67% 89% 75% 58% 100%
Stakeholder Involvement 53% 75% 8% 89% 25% 31% 67% 39% 61% 50% 8% 89%
Rigour of Development 55% 19% 53% 70% 29% 17% 77% 40% 59% 47% 17% 77%
Clarity of Presentation 72% 53% 69% 100% 61% 78% 81% 69% 67% 72% 53% 100%
Applicability 50% 15% 4% 29% 13% 27% 60% 25% 10% 26% 4% 60%
Editorial Independence 96% 0% 88% 79% 67% 25% 88% 71% 29% 60% 0% 96%
weighted mean 61% 38% 42% 73% 34% 36% 75% 45% 54% 51% 34% 75%
  1. Selected general clinical practice guidelines were rated with the AGREE-II instrument [22]. Scaled domain scores were calculated as percentage of the difference between the minimum possible score and the maximum possible score for a particular domain. Belgisch Centrum voor Evidence Based Medicine (CEBAM), Haute Autorité de Santé (HAS), American College of Physicians (ACP), Kidney Disease Improving Global Outcomes (KDIGO), Caring for Australians with Renal Insufficiency (KHA-CARI), British Colombia Medical Association (BCMA), National Institute of Health and Care Excellence (NICE), University of Michigan Health System (UMHS), Department of Veteran’s Affairs (VA-DoD)